Heartflow (HTFL) director Weldon awarded 16,075 stock options at $32.05 strike

Rhea-AI Filing Summary

Heartflow, Inc. director William C. Weldon received a new stock option grant. The award covers 16,075 stock options for Heartflow common stock at an exercise price of $32.05 per share, giving him the right to buy shares at that price in the future.

The option vests in full on the earlier of the day prior to Heartflow's 2027 annual meeting of shareholders or the first anniversary of the grant date, subject to his continued service. After this grant, he holds 16,075 options directly, and the option is scheduled to expire on June 16, 2036.

Insights

Equity Compensation Analyst

Director received a routine stock option grant as equity compensation.

Director William C. Weldon was granted 16,075 stock options with a strike price of $32.05 per share, expiring in 2036. This is classified as a grant or award acquisition, typical for director compensation.

The option vests on the earlier of the day prior to the 2027 annual shareholder meeting or one year after grant, contingent on continued service. No open-market buying or selling occurred, and there are no remaining derivative positions shown beyond this grant.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider WELDON WILLIAM C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	16,075	$32.05	$515K

Holdings After Transaction: Stock Option — 16,075 shares (Direct)

Footnotes (1)

1. F1. The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.

Key Figures

Options granted: 16,075 options Exercise price: $32.05 per share Options outstanding after grant: 16,075 options +1 more

4 metrics

Options granted 16,075 options Stock option grant to director on June 16, 2026

Exercise price $32.05 per share Strike price of newly granted stock options

Options outstanding after grant 16,075 options Total options held directly by Weldon following transaction

Option expiration date June 16, 2036 Expiration of the granted stock options

Key Terms

Stock Option, grant/award acquisition, exercise price, vest in full, +1 more

5 terms

Stock Option financial

"The award covers 16,075 stock options for Heartflow common stock"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

grant/award acquisition financial

"This is classified as a grant or award acquisition, typical for director compensation"

exercise price financial

"an exercise price of $32.05 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest in full financial

"The option vests in full on the earlier of the day prior to Heartflow's 2027 annual meeting"

annual meeting of shareholders financial

"the day prior to Heartflow's annual meeting of shareholders in 2027"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

What did Heartflow (HTFL) director William C. Weldon receive in this Form 4?

William C. Weldon received a stock option grant for 16,075 shares of Heartflow common stock. The options give him the right to buy shares at a set price as part of his director compensation package.

What is the exercise price of William C. Weldon’s new Heartflow (HTFL) stock options?

The new stock options have an exercise price of $32.05 per share. This means Weldon can purchase Heartflow common stock at $32.05 per share once the options vest, regardless of the market price at that time.

When do William C. Weldon’s Heartflow (HTFL) stock options vest?

The stock options will vest in full on the earlier of the day before Heartflow’s 2027 annual shareholder meeting or the first anniversary of the grant date, provided Weldon continues serving the company through that date.

When do the newly granted Heartflow (HTFL) stock options to Weldon expire?

The granted stock options are scheduled to expire on June 16, 2036. If they are not exercised by that expiration date, Weldon’s right to purchase Heartflow common stock at the $32.05 exercise price will lapse.

How many Heartflow (HTFL) stock options does William C. Weldon hold after this grant?

After this grant, Weldon holds 16,075 stock options directly. This entire position comes from the newly awarded option grant reported, with no additional derivative holdings shown in this particular disclosure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/18/2026 - 05:37 PM Accepted by SEC EDGAR 06/18/2026 - 05:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WELDON WILLIAM C

(Last) (First) (Middle)

C/O HEARTFLOW, INC.

135 MAIN STREET, SUITE 1000

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$32.05	06/16/2026		A		16,075		(1)	06/16/2036	Common Stock	16,075	$32.05	16,075	D

Explanation of Responses:

1. The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date.

	/s/ Nga Van, by power of attorney	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)